Surf Therapeutics
Surf Therapeutics50
About
What does Surf Therapeutics do?
Surf Therapeutics is developing a non-invasive ultrasound neuromodulation platform to treat chronic inflammatory disorders by stimulating the spleen-brain axis, known as the cholinergic anti-inflammatory pathway. Their patented BROAD-BEAM ULTRASOUND STIMULATION technology activates nerves to release neurotransmitters that signal the immune system to restore balance and calm inflammation. This platform aims to provide therapeutic benefits for conditions such as Rheumatoid Arthritis, Psoriasis/Pso…
What is Surf Therapeutics's revenue?
StartupHub estimates Surf Therapeutics's annual revenue at $1.1M (range $581K to $3.7M, 67% confidence), based on comparable companies in the sector.
What is Surf Therapeutics's valuation?
StartupHub estimates Surf Therapeutics's effective valuation at $22.6M (range $15.0M to $36.0M, 23% confidence), based on comparable companies in the sector.
How much funding has Surf Therapeutics raised?
Surf Therapeutics has raised a total of $6M in funding. The most recent round on record is Seed.
Where is Surf Therapeutics headquartered?
Surf Therapeutics is headquartered in Austin, United States.
When was Surf Therapeutics founded?
Surf Therapeutics was founded in 2022.
What industry does Surf Therapeutics operate in?
Surf Therapeutics operates in Biotechnology, Medical Devices, HealthTech, Neurology, Life Sciences.
How many employees does Surf Therapeutics have?
Surf Therapeutics has approximately 10 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.